Table 1 Baseline characteristics of adult patients with rheumatoid arthritis enrolled in Australian Rheumatology Association Database
Baseline characteristics (n = 3699) | No. (%)a |
|---|---|
Age, years, mean (SD) | 57.1 (13.0) |
Female sex | 2761 (73.4%) |
RF-positiveb | 2554/3083 (82.8%) |
ACPA-positiveb | 162/239 (67.8%) |
Disease duration, years, median (IQR) | 10 (1–34) |
Duration of ARAD follow-up, years, median (IQR) | 4 (1.5–7) |
Oral GC use | 1641 (44.4%) |
GC injection use | 740 (20.0%) |
bDMARD use | 1983 (53.6%) |
csDMARD use | 2727 (73.7%) |
bDMARD and csDMARD combined use | 1517 (41.0%) |
bDMARD use only (without csDMARD) | 466 (12.6%) |
csDMARD use only (without bDMARD) | 1210 (32.7%) |
Neither bDMARD nor csDMARD use | 506 (12.7%) |
NSAID use | 1576 (42.6%) |
Opioid use | 1174 (31.7%) |